264 related articles for article (PubMed ID: 36625657)
1. Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment.
Karaba AH; Johnston TS; Beck E; Laeyendecker O; Cox AL; Klein SL; Sullivan DJ;
mBio; 2023 Feb; 14(1):e0328722. PubMed ID: 36625657
[TBL] [Abstract][Full Text] [Related]
2. Distinct Antibody Responses to Endemic Coronaviruses Pre- and Post-SARS-CoV-2 Infection in Kenyan Infants and Mothers.
Stoddard CI; Sung K; Ojee E; Adhiambo J; Begnel ER; Slyker J; Gantt S; Matsen FA; Kinuthia J; Wamalwa D; Overbaugh J; Lehman DA
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891497
[TBL] [Abstract][Full Text] [Related]
3. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
Asamoah-Boaheng M; Grunau B; Karim ME; Jassem AN; Bolster J; Marquez AC; Scheuermeyer FX; Goldfarb DM
Front Immunol; 2022; 13():954093. PubMed ID: 36159791
[TBL] [Abstract][Full Text] [Related]
4. Humoral response to SARS-CoV-2 and seasonal coronaviruses in COVID-19 patients.
Adams O; Andrée M; Rabl D; Ostermann PN; Schaal H; Lehnert E; Ackerstaff S; Müller L; Fischer JC
J Med Virol; 2022 Mar; 94(3):1096-1103. PubMed ID: 34716706
[TBL] [Abstract][Full Text] [Related]
5. High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients.
Greenbaum U; Klein K; Martinez F; Song J; Thall PF; Ramdial JL; Knape C; Aung FM; Scroggins J; Knopfelmacher A; Mulanovich V; Borjan J; Adachi J; Muthu M; Leung C; Medina MC; Champlin R; Olson A; Alousi A; Rezvani K; Shpall EJ
Front Immunol; 2021; 12():675679. PubMed ID: 33995420
[TBL] [Abstract][Full Text] [Related]
6. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies constructed from COVID-19 convalescent memory B cells exhibit potent binding activity to MERS-CoV spike S2 subunit and other human coronaviruses.
Peng Y; Liu Y; Hu Y; Chang F; Wu Q; Yang J; Chen J; Teng S; Zhang J; He R; Wei Y; Bostina M; Luo T; Liu W; Qu X; Li YP
Front Immunol; 2022; 13():1056272. PubMed ID: 36618428
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
Trials; 2021 May; 22(1):342. PubMed ID: 34001174
[TBL] [Abstract][Full Text] [Related]
10. Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.
Adami FL; de Castro MV; Almeida BDS; Daher IP; Yamamoto MM; Souza Santos K; Zatz M; Naslavsky MS; Rosa DS; Cunha-Neto E; de Oliveira VL; Kalil J; Boscardin SB
Front Immunol; 2024; 15():1396603. PubMed ID: 38846944
[TBL] [Abstract][Full Text] [Related]
11. Distinct antibody responses to endemic coronaviruses pre- and post-SARS-CoV-2 infection in Kenyan infants and mothers.
Stoddard CI; Sung K; Ojee E; Adhiambo J; Begnel ER; Slyker J; Gantt S; Matsen FA; Kinuthia J; Wamalwa D; Overbaugh J; Lehman DA
bioRxiv; 2022 Jun; ():. PubMed ID: 35677071
[TBL] [Abstract][Full Text] [Related]
12. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses.
Sampson AT; Heeney J; Cantoni D; Ferrari M; Sans MS; George C; Di Genova C; Mayora Neto M; Einhauser S; Asbach B; Wagner R; Baxendale H; Temperton N; Carnell G
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452443
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study.
Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J
Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013
[TBL] [Abstract][Full Text] [Related]
15. High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines.
Joseph JO; Ylade M; Daag JV; Aogo R; Crisostomo MV; Mpingabo P; Premkumar L; Deen J; Katzelnick L
Res Sq; 2023 Nov; ():. PubMed ID: 38014070
[TBL] [Abstract][Full Text] [Related]
16. Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality.
Morgenlander WR; Henson SN; Monaco DR; Chen A; Littlefield K; Bloch EM; Fujimura E; Ruczinski I; Crowley AR; Natarajan H; Butler SE; Weiner JA; Li MZ; Bonny TS; Benner SE; Balagopal A; Sullivan D; Shoham S; Quinn TC; Eshleman SH; Casadevall A; Redd AD; Laeyendecker O; Ackerman ME; Pekosz A; Elledge SJ; Robinson M; Tobian AA; Larman HB
J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33571169
[TBL] [Abstract][Full Text] [Related]
17. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study.
Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A
Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
[TBL] [Abstract][Full Text] [Related]
19. Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients.
Tornesello AL; Botti C; Micillo A; Labonia F; Arpino S; Isgrò MA; Meola S; Russo L; Cavalcanti E; Sale S; Nicastro C; Atripaldi L; Starita N; Cerasuolo A; Reimer U; Holenya P; Buonaguro L; Buonaguro FM; Tornesello ML
J Transl Med; 2023 Feb; 21(1):123. PubMed ID: 36788606
[TBL] [Abstract][Full Text] [Related]
20. High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples.
Anand SP; Prévost J; Richard J; Perreault J; Tremblay T; Drouin M; Fournier MJ; Lewin A; Bazin R; Finzi A
Transfusion; 2021 May; 61(5):1377-1382. PubMed ID: 33604922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
